It is common to confuse "CL4" with (Cytotoxic T-Lymphocyte Antigen 4). Unlike the experimental CL4 aptamer, CTLA-4 inhibitors are a well-established class of FDA-approved immunotherapy.
: CL4 is available through specialized biotechnology suppliers and molecular tool laboratories (such as Quality4Lab ) exclusively for in vitro and in vivo laboratory research.
At present, is primarily a research-grade molecular tool rather than a commercially available medication for public purchase. If you are looking for "CL4" in the context of cancer treatment, it most likely refers to a specialized RNA aptamer currently being studied in laboratory settings. What is CL4?
CL4 is a specifically designed to target the Epidermal Growth Factor Receptor (EGFR) . EGFR is a protein often found in high amounts on the surface of certain cancer cells, such as those in triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) . In laboratory research, CL4 has shown promise by: Binding specifically to cancer cells that overexpress EGFR.
for other drugs, such as doxorubicin, to help them target tumors more effectively. Where to "Buy" CL4
: Medications like Yervoy (Ipilimumab) and Imjudo (Tremelimumab) are used to treat melanoma, lung cancer, and colorectal cancer.
: These are prescription-only treatments administered via infusion in clinical settings. Important Safety Warning CL4 - Aptamer - quality4lab.cnr.it
that allow tumors to grow, leading to selective cell death.